ERAS-0015

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameERAS-0015
Drug Alias NameERAS-0015JYP0015JYP-0015
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHematologic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Jiayue Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Jiayue Pharmaceutical Technology Co LtdErasca Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHematologic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A